Funding for this research was provided by:
Received: 18 May 2022
Accepted: 13 September 2022
First Online: 24 September 2022
: The PRINT trial was approved by the ethics committee of the University Medicine Greifswald, Germany (protocol number BB 147/15). Additional follow-ups to investigate long-term intervention effects were approved by the ethics committees of University Medicine Greifswald (protocol number BB 053/19) and TU Dresden (protocol number SR-EK-272062020). All participants provided written informed consent. All methods were performed in accordance with the relevant guidelines and regulations, in particular the Declaration of Helsinki.
: Not applicable.